MSD to Acquire Verona Pharma for $10 Billion, Expanding Respiratory Portfolio
In a landmark deal poised to reshape the respiratory disease treatment landscap US pharmaceutical giant...
NASDAQ: VRNA
Nuance Pharma Gets NMPA Green Light for Ensifentrine COPD Trials in China
China-based Nuance Pharma has secured approval from the National Medical Products Administration (NMPA) to conduct...